The guidance raise and strong same-facility occupancy/skilled mix trends signal accelerating organic growth. Traders should watch for continued acquisition momentum in H2 2026 and monitor the Q3 2026 earnings call for any changes to the reimbursement or regulatory environment.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 27 $178.07entry
- T+1 · 4mo ago +2.85%α +2.61% · $183.14
- T+5 · 4mo ago +0.05%α −1.02% · $178.16
- T+20 · 3mo ago +0.73%α −2.57% · $179.37
- T+60 · 28d ago −2.82%α −6.53% · $173.05
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The Ensign Group reported Q2 2026 GAAP diluted EPS of $1.68 (up 16.7% YoY) and adjusted EPS of $1.92 (up 20.8% YoY), with total revenue of $1.44B (+17.3% YoY). The company raised its full-year 2026 EPS guidance to $7.75-$7.85 and revenue guidance to $5.87B-$5.92B, reflecting strong operational momentum driven by occupancy gains, skilled mix improvement, and disciplined acquisition growth. The beat was modest vs consensus ($1.85 EPS on $1.44B revenue), but the guidance raise and robust clinical/operating metrics support a bullish outlook.
Key Financial Metrics
Key Facts
- GAAP diluted EPS of $1.68, +16.7% YoY; adjusted EPS of $1.92, +20.8% YoY
- Total revenue $1.44B, +17.3% YoY; service revenue $1.43B, +17.3% YoY
- Same-facility occupancy 84.1% (+2.7pp YoY); skilled mix revenue +10.1% YoY
- Raised FY2026 EPS guidance to $7.75-$7.85 (midpoint +18.7% vs 2025) and revenue to $5.87B-$5.92B
- Added 20 new operations in Q2, all with real estate; portfolio now 398 facilities across 17 states
- Standard Bearer FFO $24.7M (+34.6% YoY); rental revenue $44.1M (+40.2% YoY)
- Cash and credit facility liquidity ~$854M; paid quarterly dividend of $0.065/share
Financial Impact
Revenue $1.44B (+17.3% YoY), GAAP net income $99.7M (+18.2% YoY), adjusted net income $114.3M (+22.5% YoY)
Risk Factors
- Medicaid/Medicare reimbursement rate changes or regulatory shifts
- Integration risk from rapid acquisition pace (20 new operations in Q2)
- Labor cost inflation and nursing staff shortages could pressure margins
- Occupancy at recently acquired facilities (76.6%) trails same-facility levels (84.1%)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3333337 |
Track record
19 reports on ENSG
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +5.67% at T+20 after the Oct 2, 2026 report. 3 of 3 went positive at some point.
Filters
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $184.11 to $188.31 Now $188.23 +2.24% ▲ +2.28% +2.99% vs SPY
- Oct 27, 202620d ago 8-K Bullish 6/10 No price data
- Oct 27, 202620d ago Press Release Bullish 6/10 Entry $184.11 to $188.31 Now $188.23 +2.24% ▲ +2.28% +2.99% vs SPY
- Oct 23, 202624d ago Press Release Neutral 1/10 Entry $176.92 to $181.52 Now $188.23 +6.39% ▲ +2.60% +3.86% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $175.59 to $181.52 Now $188.23 +7.20% ▲ +3.38% +3.94% vs SPY
- Oct 2, 20266w ago Press Release Neutral 5/10 Entry $171.78 to $171.80 Now $188.23 +9.58% ▲ +0.01% −1.15% vs SPY
- Oct 2, 20266w ago Press Release Neutral 4/10 Entry $171.78 to $171.80 Now $188.23 +9.58% ▲ +0.01% −1.15% vs SPY
- Oct 2, 20266w ago Press Release Bullish 6/10 Entry $171.78 to $171.80 Now $188.23 +9.58% ▲ +0.01% −1.15% vs SPY
- Sep 18, 20268w ago Press Release Neutral 2/10 Entry $173.91 to $175.18 Now $188.23 +8.23% ▲ +0.73% −0.54% vs SPY
- Jul 27, 202616w ago 8-K Bullish 7/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers